Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-α and dexamethasone

Respiratory Research

Volumn 9, Issue , 2008, Pages

  Tirumurugaan, Krishnaswamy G ^a   Kang, Bit N ^a   Panettieri, Reynold A ^b   Foster, Douglas N ^c   Walseth, Timothy F ^c   Kannan, Mathur S ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CD38 PROTEIN, HUMAN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MEMBRANE PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRONCHUS HYPERREACTIVITY; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROMOTER REGION; SMOOTH MUSCLE FIBER; TRACHEA;

ANTIGENS, CD38; BRONCHIAL HYPERREACTIVITY; CELLS, CULTURED; DEXAMETHASONE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; LUCIFERASES; MEMBRANE GLYCOPROTEINS; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RECEPTORS, GLUCOCORTICOID; TRACHEA; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42949129186     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-9-26     Document Type: Article

References (53)

1. Lee HC. Enzymatic functions and structures of CD38 and homologs. Chem Immunol 2000, 75:39-59.
2. Lee HC, Graeff RM, Walseth TF. ADP-ribosyl cyclase and CD38. Multi-functional enzymes in Ca+2 signaling. Adv Exp Med Biol 1997, 419:411-9.
3. Mehta K, Shahid U, Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J 1996, 10:1408-17.
4. White TA, Johnson S, Walseth TF, Lee HC, Graeff RM, Munshi CB, Prakash YS, Sieck GC, Kannan MS. Subcellular localization of cyclic ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities in porcine airway smooth muscle. Biochim Biophys Acta 2000, 1498:64-71. 10.1016/S0167-4889(00)00077-X, 11042351.
5. Deshpande DA, Walseth TF, Panettieri RA, Kannan MS. CD38/cyclic ADP-ribose-mediated Ca2+ signaling contributes to airway smooth muscle hyper-responsiveness. FASEB J 2003, 17:452-4.
6. White TA, Kannan MS, Walseth TF. Intracellular calcium signaling through the cADPR pathway is agonist specific in porcine airway smooth muscle. FASEB J 2003, 17:482-4.
7. Deshpande DA, White TA, Dogan S, Walseth TF, Panettieri RA, Kannan MS. CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2005, 288:L773-88. 10.1152/ajplung.00217.2004, 15821018.
8. Deshpande DA, Dogan S, Walseth TF, Miller SM, Amrani Y, Panettieri RA, Kannan MS. Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am J Respir Cell Mol Biol 2004, 31:36-42. 10.1165/rcmb.2003-0313OC, 14764428.
9. Kang BN, Tirumurugaan KG, Deshpande DA, Amrani Y, Panettieri RA, Walseth TF, Kannan MS. Transcriptional regulation of CD38 expression by tumor necrosis factor-alpha in human airway smooth muscle cells: role of NF-kappaB and sensitivity to glucocorticoids. FASEB J 2006, 20:1000-2. 10.1096/fj.05-4585fje, 16571778.
10. Tirumurugaan KG, Jude JA, Kang BN, Panettieri RA, Walseth TF, Kannan MS. TNF-alpha induced CD38 expression in human airway smooth muscle cells: role of MAP kinases and transcription factors NF-kappaB and AP-1. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1385-95. 10.1152/ajplung.00472.2006, 17322278.
11. Barnes PJ. Drugs for asthma. Br J Pharmacol 2006, 147(Suppl 1):S297-303. 1760737, 16402117, 10.1038/sj.bjp.0706437.
12. Beato M. Gene regulation by steroid hormones. Cell 1989, 56:335-44. 10.1016/0092-8674(89)90237-7, 2644044.
13. Kishimoto H, Hoshino S, Ohori M, Kontani K, Nishina H, Suzawa M, Kato S, Katada T. Molecular mechanism of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron. J Biol Chem 1998, 273:15429-34. 10.1074/jbc.273.25.15429, 9624127.
14. Sun L, Iqbal J, Zaidi S, Zhu LL, Zhang X, Peng Y, Moonga BS, Zaidi M. Structure and functional regulation of the CD38 promoter. Biochem Biophys Res Commun 2006, 341:804-9. 10.1016/j.bbrc.2006.01.033, 16442077.
15. Sugiyama T, Scott DK, Wang JC, Granner DK. Structural requirements of the glucocorticoid and retinoic acid response units in the phosphoenolpyruvate carboxykinase gene promoter. Mol Endocrinol 1998, 12:1487-98. 10.1210/me.12.10.1487, 9773973.
16. Scott DK, Stromstedt PE, Wang JC, Granner DK. Further characterization of the glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. The role of the glucocorticoid receptor-binding sites. Mol Endocrinol 1998, 12:482-91. 10.1210/me.12.4.482, 9544984.
17. Ferrero E, Saccucci F, Malavasi F. The making of a leukocyte receptor: origin, genes and regulation of human CD38 and related molecules. Chem Immunol 2000, 75:1-19.
18. Mehta K. Retinoid-mediated signaling in CD38 antigen expression. Chem Immunol 2000, 75:20-38.
19. Nata K, Takamura T, Karasawa T, Kumagai T, Hashioka W, Tohgo A, Yonekura H, Takasawa S, Nakamura S, Okamoto H. Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): organization, nucleotide sequence and alternative splicing. Gene 1997, 186:285-92. 10.1016/S0378-1119(96)00723-8, 9074508.
20. Ernst P, Smale ST. Combinatorial regulation of transcription. I: General aspects of transcriptional control. Immunity 1995, 2:311-9. 10.1016/1074-7613(95)90139-6, 7719936.
21. Ferrero E, Malavasi F. Human CD38, a leukocyte receptor and ectoenzyme, is a member of a novel eukaryotic gene family of nicotinamide adenine dinucleotide+-converting enzymes: extensive structural homology with the genes for murine bone marrow stromal cell antigen 1 and aplysian ADP-ribosyl cyclase. J Immunol 1997, 159:3858-65.
22. Ferrero E, Saccucci F, Malavasi F. The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene. Immunogenetics 1999, 49:597-604. 10.1007/s002510050654, 10369916.
23. Dogan S, Deshpande DA, Kannan MS, Walseth TF. Changes in CD38 expression and ADP-ribosyl cyclase activity in rat myometrium during pregnancy: influence of sex steroid hormones. Biol Reprod 2004, 71:97-103. 10.1095/biolreprod.103.026245, 14998907.
24. Dogan S, White TA, Deshpande DA, Murtaugh MP, Walseth TF, Kannan MS. Estrogen increases CD38 gene expression and leads to differential regulation of adenosine diphosphate (ADP)-ribosyl cyclase and cyclic ADP-ribose hydrolase activities in rat myometrium. Biol Reprod 2002, 66:596-602. 10.1095/biolreprod66.3.596, 11870063.
25. Dogan S, Deshpande DA, White TA, Walseth TF, Kannan MS. Regulation of CD 38 expression and function by steroid hormones in myometrium. Mol Cell Endocrinol 2006, 246:101-6. 10.1016/j.mce.2005.11.014, 16388888.
26. Riffo-Vasquez Y, Pitchford S, Spina D. Cytokines in airway inflammation. Int J Biochem Cell Biol 2000, 32:833-53. 10.1016/S1357-2725(00)00029-7, 10940641.
27. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992, 89:958-67. 10.1016/0091-6749(92)90218-Q, 1374772.
28. Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, Amrani Y, Penn RB, Panettieri RA. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol 2002, 26:465-74.
29. Amrani Y, Chen H, Panettieri RA. Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyper-responsiveness in asthma?. Respir Res 2000, 1:49-53. 59542, 11667965, 10.1186/rr12.
30. Tliba O, Panettieri RA, Tliba S, Walseth TF, Amrani Y. Tumor necrosis factor-alpha differentially regulates the expression of proinflammatory genes in human airway smooth muscle cells by activation of interferon-beta-dependent CD38 pathway. Mol Pharmacol 2004, 66:322-9. 10.1124/mol.104.001040, 15266023.
31. Chikanza IC, Kozaci D, Chernajovsky Y. The molecular and cellular basis of corticosteroid resistance. J Endocrinol 2003, 179:301-10. 10.1677/joe.0.1790301, 14656201.
32. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995, 270:283-6. 10.1126/science.270.5234.283, 7569975.
33. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270:286-90. 10.1126/science.270.5234.286, 7569976.
34. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 1996, 17:245-61. 10.1210/er.17.3.245, 8771358.
35. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995, 9:2723-35. 10.1101/gad.9.22.2723, 7590248.
36. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable?. Cell 1998, 93:487-90. 10.1016/S0092-8674(00)81177-0, 9604923.
37. Doucas V, Shi Y, Miyamoto S, West A, Verma I, Evans RM. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 2000, 97:11893-8. 17265, 11027313, 10.1073/pnas.220413297.
38. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990, 62:1205-15. 10.1016/0092-8674(90)90396-V, 2169352.
39. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990, 62:1217-26. 10.1016/0092-8674(90)90397-W, 2169353.
40. Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH, Winkler H. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem 1996, 271:19612-6. 10.1074/jbc.271.32.19612, 8702657.
41. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 1998, 12:45-56. 10.1210/me.12.1.45, 9440809.
42. Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990, 62:1189-204. 10.1016/0092-8674(90)90395-U, 2169351.
43. Kerppola TK, Luk D, Curran T. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol Cell Biol 1993, 13:3782-91. 359861, 8497279.
44. Nie M, Knox AJ, Pang L. beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. J Immunol 2005, 175:478-86.
45. Tliba O, Cidlowski JA, Amrani Y. CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-alpha and interferon-gamma by a mechanism involving the up-regulation of the glucocorticoid receptor beta isoform. Mol Pharmacol 2006, 69:588-96. 10.1124/mol.105.019679, 16291871.
46. Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989, 58:227-9. 10.1016/0092-8674(89)90833-7, 2665943.
47. Cousin E, Medcalf RL, Bergonzelli GE, Kruithof EK. Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res 1991, 19:3881-6. 328478, 1650454, 10.1093/nar/19.14.3881.
48. Lee W, Mitchell P, Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 1987, 49:741-52. 10.1016/0092-8674(87)90612-X, 3034433.
49. Lopez-Bayghen E, Vega A, Cadena A, Granados SE, Jave LF, Gariglio P, Alvarez-Salas LM. Transcriptional analysis of the 5'-noncoding region of the human involucrin gene. J Biol Chem 1996, 271:512-20. 10.1074/jbc.271.25.15175, 8550612.
50. Minta JO, Fung M, Turner S, Eren R, Zemach L, Rits M, Goldberger G. Cloning and characterization of the promoter for the human complement factor I (C3b/C4b inactivator) gene. Gene 1998, 208:17-24. 10.1016/S0378-1119(97)00632-X, 9479036.
51. Risse G, Jooss K, Neuberg M, Bruller HJ, Muller R. Asymmetrical recognition of the palindromic AP1 binding site (TRE) by Fos protein complexes. EMBO J 1989, 8:3825-32. 402070, 2511003.
52. Sweetser MT, Hoey T, Sun YL, Weaver WM, Price GA, Wilson CB. The roles of nuclear factor of activated T cells and ying-yang 1 in activation-induced expression of the interferon-gamma promoter in T cells. J Biol Chem 1998, 273:34775-83. 10.1074/jbc.273.52.34775, 9857002.
53. Beato M. Gene regulation by steroid hormones. Cell 1989, 56:335-44. 10.1016/0092-8674(89)90237-7, 2644044.